Abstract: A purification method of fungal cell wall composition includes following steps: (1) taking a residue of a fungus fruiting body underwent extraction process for obtaining extract thereof, wherein the extract contains terpenoids, sterols, polysaccharides, or a combination thereof, and the residue contains the cell wall of the fruiting body; (2) placing the residue into an aqueous percarbonate solution to form a mixture liquid, which is reacted at a first temperature for decolorizing the residue, wherein the concentration of the aqueous percarbonate solution ranges from 5 to 20% (w/v), and the first temperature ranges from 15 to 40° C.; (3) after the decolorization process, raising the temperature of the mixture liquid to a second temperature for the mixture liquid to react, so as to digest and decompose the residue, wherein the second temperature ranges from 80 to 100° C.; and (4) filtering the treated mixture liquid to obtain a purified product.

Abstract: A purification method of fungal cell wall composition includes following steps: (1) taking a residue of a fungus fruiting body underwent extraction process for obtaining extract thereof, wherein the extract contains terpenoids, sterols, polysaccharides, or a combination thereof, and the residue contains the cell wall of the fruiting body; (2) placing the residue into an aqueous percarbonate solution to form a mixture liquid, which is reacted at a first temperature for decolorizing the residue, wherein the concentration of the aqueous percarbonate solution ranges from 5 to 20% (w/v), and the first temperature ranges from 15 to 40° C.; (3) after the decolorization process, raising the temperature of the mixture liquid to a second temperature for the mixture liquid to react, so as to digest and decompose the residue, wherein the second temperature ranges from 80 to 100° C.; and (4) filtering the treated mixture liquid to obtain a purified product.

Abstract: The invention provides anti-CaENO1 antibodies and humanized antibodies as effective diagnostic agent or therapeutic treatment against infections caused by Candida spp. (preferably Candida. albicans, Candida tropicalis), fluconazole resistance Candida spp., Streptococcus, or Staphylococcus.

Abstract: The invention provides anti-CaENO1 antibodies and humanized antibodies as effective diagnostic agent or therapeutic treatment against infections caused by Candida spp. (preferably Candida. albicans, Candida tropicalis), fluconazole resistance Candida spp., Streptococcus, or Staphylococcus.

Abstract: Disclosures of the present invention describe a method of treatment of cancer cells by using pharmaceutical composition. In the present invention, it particularly adopts an ethanol extract of Taiwanofungus camphorata (TCEE), an ethanol extract of Ganoderma lucidum (GLEE) or a combination of the TCEE and the GLEE as the a pharmaceutical composition for use in causing the apoptosis of lung cancer cells A594, hepatoma cells Huh 7, breast cancer cells MDA-MB 231, and colorectal cancer cells HT 29. Moreover, related experimental data have proved that, the pharmaceutical composition can not only be used for adjunctively treating cancer, but also possesses many healthy effects, including: detoxification, enhancing immunity, and increasing appetite.

Abstract: Anti-CaENO1 antibodies and humanized antibodies are provided as an effective diagnostic agent or a therapeutic treatment against infections caused by Candida spp., preferably Candida albicans, Candida tropicalis, fluconazole resistance Candida spp., Streptococcus, Staphylococcus.

Abstract: A 3D printing method implemented by swaths is disclosed. When printing swaths of a printing layer, a 3D printer first obtains a default swath-width, and adjusts the default swath-width based on a shift value, then controls a nozzle to print the swaths according to the adjusted swath-width. When printing a final swath of the same printing layer, the 3D printer compensates a remained swath-width of the final swath according to the adjusted shift value(s) of previous printed swath(s), and controls the nozzle to print the final swath according to the compensated remained swath-width. When printing different printing layers, the 3D printer uses different shift values to adjust the swath-width of each printing layer. Because swaths of different printing layers have different widths, the positions of seams between each two swaths of each printing layer are staggered, and thus the strength of printed 3D models is enhanced.

Abstract: A 3D printing apparatus including a 3D printing device, a VR display device, and a processing device is provided. The VR display device displays a VR image. The VR display device includes an input device. The input device receives an input signal and the input signal in response to selecting a virtual object in the VR image. The processing device obtains a generic model data corresponding to the virtual object based on the input signal. The processing device executes an edit module to edit a 3D model corresponding to the virtual object based on the generic model data. When the processing device outputs a plurality of layered data corresponding to the 3D model to the 3D printing device, the 3D printing device prints a 3D object corresponding to the 3D model based on the plurality of layered data. Moreover, a 3D printing method is also provided.

Abstract: A 3D printing method adapted to a 3D printing apparatus is provided. The 3D printing apparatus is configured to edit a plurality of sliced images, and execute a 3D printing operation according to the edited sliced images. The 3D printing method includes: analyzing a plurality of sliced objects of the sliced images, so as to draw a plurality of sliced object casings according to individual contours of the sliced objects, where the sliced object casings respectively include a part of the sliced objects; and respectively deleting the other parts of the sliced objects outside the sliced object casings, and integrating the sliced object casings of the sliced images to obtain a 3D model casing. Moreover, the 3D printing apparatus applying the 3D printing method is also provided.

Abstract: Disclosures of the present invention describe an unsaturated-fatty-acid-containing vegetarian composition, wherein the said composition is composed by at least one vegetable oil and at least one algal oil, and rich in Omega-3, Omega-6 and Omega-9. The present invention particularly design the constituting ratio of Omega-3, Omega-6, and Omega-9 in order to facilitate the content levels of Omega-3 and Omega-6 in the body of a vegetarian administering the vegetarian composition of the present invention reach an ideal balance state. Moreover, it is worth introducing that, this vegetarian composition can be accommodated by a vegetable capsule shell, so as to become a capsule type of dietary supplement. Therefore, it is a great relief for vegetarians to administer the vegetarian composition containing unsaturated fatty acids because the vegetarian composition is made of vegan materials.

Abstract: Disclosures of the present invention describe a method of treatment of cancer cells by using pharmaceutical composition. In the present invention, it particularly adopts an ethanol extract of Taiwanofungus camphorata (TCEE), an ethanol extract of Ganoderma lucidum (GLEE) or a combination of the TCEE and the GLEE as the a pharmaceutical composition for use in causing the apoptosis of lung cancer cells A594, hepatoma cells Huh 7, breast cancer cells MDA-MB 231, and colorectal cancer cells HT 29. Moreover, related experimental data have proved that, the pharmaceutical composition can not only be used for adjunctively treating cancer, but also possesses many healthy effects, including: detoxification, enhancing immunity, and increasing appetite.

Abstract: A method and a system of three-dimensional (3D) printing are provided. The method of 3D printing is adapted to a 3D printing apparatus and includes following steps: slicing a 3D object model into a plurality of sub-slicing layers according to a printing plane; merging a default number of adjacent sub-slicing layers into a plurality of grey-scale slicing layers; and, printing a 3D object according to the grey-scale slicing layers. The thickness of each sub-slicing layer is thinner than the thickness of a default layer used whenever the 3D printing apparatus performs a single printing process. The thickness of each of the grey-scale slicing layers is equal to the thickness of the default layer used whenever the 3D printing apparatus performs the single printing process.

Abstract: An anti-cancer drug composition includes a Ganoderma extract having a concentration of 1-5 mg/ml and an amphotericin B having a concentration of 3-10 ?M. The Ganoderma extract and the amphotericin B are medicated at different times by pre-treating cancer cells with the Ganoderma extract for a period of time followed by administration of the amphotericin B to enhance an anti-cancer effect of the amphotericin B.

Abstract: A 3D printing method implemented by movable platform is disclosed. When printing a printing layer, a 3D printer first calculates respectively a starting point and an ending point of each swath of the printing layer, and calculates movement information of a movable printing platform upon an X-axis and a Y-axis of the 3D printer according to the starting points and the ending points. Next, the 3D printer controls the printing platform to move along the X-axis and the Y-axis based on the movement information, and controls a nozzle of the 3D printer to jet ink while the printing platform moves to corresponding positions. Therefore, the 3D printer uses the printing platform to complete printing actions of each swath.

Abstract: A 3D printing apparatus including a 3D printing device, a VR display device, and a processing device is provided. The VR display device displays a VR image. The VR display device includes an input device. The input device receives an input signal and the input signal in response to selecting a virtual object in the VR image. The processing device obtains a generic model data corresponding to the virtual object based on the input signal. The processing device executes an edit module to edit a 3D model corresponding to the virtual object based on the generic model data. When the processing device outputs a plurality of layered data corresponding to the 3D model to the 3D printing device, the 3D printing device prints a 3D object corresponding to the 3D model based on the plurality of layered data. Moreover, a 3D printing method is also provided.

Abstract: The present invention provides a composition for inhibiting renal cancer cell growth and enhancing kidney function. This composition is constituted of water-soluble base material, plasticity-increasing base material, Antrodia camphorata extract, Ganoderma lucidum extract, and auxiliary enzyme. Differing from the conventional therapeutics treating the glomerulonephritis by administering high-dosage steroid for 1-4 months, the renal function of a patient suffering with serious kidney failure can be obviously enhanced after administering this composition of 7 mg/day/kg to the patient for 20 days. Moreover, because the cell biological experiments have proved that the of the present invention possess the functionality to inhibit renal cancer cell growth, this novel composition can indeed be used with chemotherapy drugs clinically, so as to solve the issue that the chemotherapy drugs cannot effectively inhibit the renal cancer cell growth.

Abstract: A 3D printing method adapted to a 3D printing apparatus is provided. The 3D printing apparatus is configured to edit a plurality of sliced images, and execute a 3D printing operation according to the edited sliced images. The 3D printing method includes: analyzing a plurality of sliced objects of the sliced images, so as to draw a plurality of sliced object casings according to individual contours of the sliced objects, where the sliced object casings respectively include a part of the sliced objects; and respectively deleting the other parts of the sliced objects outside the sliced object casings, and integrating the sliced object casings of the sliced images to obtain a 3D model casing. Moreover, the 3D printing apparatus applying the 3D printing method is also provided.

Abstract: The present invention provides a composition for enhancing immunity. Differing from all commercial vitamin healthcare foods would cause some adverse effects due to excessive vitamin intake, the present invention proposes a Solanum nigrum-fermented product to be a novel composition for enhancing immunity. Moreover, animal experimental results have proved that, this novel composition would not cause any adverse effects (such as poor appetite or liver damage) even if an adult excessively administer the novel composition. In addition, comparing with the commercial healthcare foods always being made to tablets, the Solanum nigrum-fermented product (i.e., the novel composition) can be processed to various forms, such as powder, tablet, capsule, and drink.

Abstract: The present invention provides a method for manufacturing fungal pharmaceutical composition, used for extracting a glycosaminoglycan fiber from a fungal cell wall. Differing from the glycosaminoglycan fiber produced by using a fabrication method proposed by Taiwan patent No. 442496 showing many drawbacks including low extraction percentage, coarse fiber, and having light-yellow color, the glycosaminoglycan fiber manufactured by using this novel method reveals the advantages of high extraction percentage, fine fibers, and showing white color. So that, the novel glycosaminoglycan fiber produced by using the present invention's method is suitable for being processed to an excipient.

Abstract: A method and a system of three-dimensional (3D) printing are provided. The method of 3D printing is adapted to a 3D printing apparatus and includes following steps: slicing a 3D object model into a plurality of sub-slicing layers according to a printing plane; merging a default number of adjacent sub-slicing layers into a plurality of grey-scale slicing layers; and, printing a 3D object according to the grey-scale slicing layers. The thickness of each sub-slicing layer is thinner than the thickness of a default layer used whenever the 3D printing apparatus performs a single printing process. The thickness of each of the grey-scale slicing layers is equal to the thickness of the default layer used whenever the 3D printing apparatus performs the single printing process.